World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
Austria
2026

D-Index & Metrics

Neuroscience

D-Index
124
Citations
59305
World Ranking
335
National Ranking
5

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Austria Leader Award
  • 2025 - Research.com Neuroscience in Austria Leader Award
  • 2020 - Member of Academia Europaea
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Siegfried Kasper is affiliated with the Medical University of Vienna in Austria and has contributed extensively to the fields of medicine and neuroscience. Their research spans numerous subfields including pharmacology, psychiatry and mental health, experimental and cognitive psychology, cognitive neuroscience, and biological psychiatry.

The main focus of Kasper's work centers on the treatment of major depression, with additional attention to tryptophan and brain disorders, functional brain connectivity studies, mental health research topics, anxiety, depression, psychometrics, treatment, cognitive processes, bipolar disorder and treatment, as well as schizophrenia research and treatment.

Kasper has collaborated frequently with several researchers, notably Rupert Lanzenberger, Lucie Bartova, Daniel Souery, Joseph Zohar, and Alessandro Serretti. These collaborations have contributed to the extensive output of scientific literature.

Their publications are often found in prominent academic journals, with a significant number appearing in venues such as:

  • European Neuropsychopharmacology (12 publications)
  • The International Journal of Neuropsychopharmacology (10 publications)
  • Journal of Affective Disorders (9 publications)
  • The World Journal of Biological Psychiatry (8 publications)
  • International Journal of Psychiatry in Clinical Practice (8 publications)

Some notable recent papers relevant to their research interests include:

  • "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation" (2021, American Journal of Psychiatry)
  • "Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions" (2023, World Psychiatry)
  • "Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)" (2020, The International Journal of Neuropsychopharmacology)
  • "Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression" (2020, The Journal of Clinical Psychiatry)
  • "The identification, assessment and management of difficult-to-treat depression: An international consensus statement" (2020, Journal of Affective Disorders)

Siegfried Kasper has been recognized with memberships in scholarly communities, including being a member of Academia Europaea since 2020 and a member of the European Academy of Sciences and Arts.

Best Publications

  • Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.

    Siegfried Kasper;Thomas A. Wehr;John J. Bartko;Paul A. Gaist

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

    Borwin Bandelow;Josef Zohar;Eric Hollander;Siegfried Kasper

  • Social functioning in depression: a review

    Robert M.A. Hirschfeld;Stuart A. Montgomery;Martin B. Keller;Siegfried Kasper

  • Prevalence of seasonal affective disorder at four latitudes.

    Leora N. Rosen;Steven D. Targum;Michael Terman;Michael J. Bryant

  • Updated European Consensus Statement on Diagnosis and Treatment of Adult ADHD

    J.J.S. Kooij;D. Bijlenga;L. Salerno;R. Jaeschke

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

    Daniel Souery;Pierre Oswald;Isabelle Massat;Ursula Bailer

  • CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

    J Kirchheiner;K Brosen;Marja-Liisa Dahl;LF Gram

  • Prognosis and improved outcomes in major depression: a review

    Christoph Kraus;Christoph Kraus;Bashkim Kadriu;Rupert Lanzenberger;Carlos A. Zarate Jr.

  • The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

    Guy M. Goodwin;Charles L. Bowden;Joseph R. Calabrese;Heinz Grunze

  • Guidelines for the pharmacological treatment of anxiety disorders, obsessive - compulsive disorder and posttraumatic stress disorder in primary care

    Borwin Bandelow;Leo Sher;Robertas Bunevicius;Eric Hollander

  • Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder.

    Andreas Hahn;Patrycja Stein;Christian Windischberger;Andreas Weissenbacher

  • Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression.

    Christoph Kraus;Eero Castrén;Siegfried Kasper;Rupert Lanzenberger

  • Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

    Siegfried Kasper;Mark N. Lerman;Robert D. McQuade;Anutosh Saha

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • The serotonin-1A receptor in anxiety disorders.

    Elena Akimova;Rupert Lanzenberger;Siegfried Kasper

  • Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.

    Carolina Johansson;Matthäeus Willeit;Christina Smedh;Jenny Ekholm

  • Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.

    Jean Pierre Olié;Siegfried Kasper

Frequent Co-Authors

Andreas Hahn
Andreas Hahn University of Giessen
Julien Mendlewicz
Julien Mendlewicz Université Libre de Bruxelles
Stuart Montgomery
Stuart Montgomery Imperial College London
Georg S. Kranz
Georg S. Kranz Hong Kong Polytechnic University
Alessandro Serretti
Alessandro Serretti Kore University of Enna
Joseph Zohar
Joseph Zohar Sheba Medical Center
Christian Windischberger
Christian Windischberger Medical University of Vienna
Susanne Asenbaum
Susanne Asenbaum Medical University of Vienna
H.-J. Möller
H.-J. Möller Ludwig-Maximilians-Universität München
Raffaella Calati
Raffaella Calati University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to a range of online degrees and specialized career options. Many students who pursue neuroscience also consider advanced programs in psychology and therapy. For those interested in clinical practice, there are psyd programs online that offer flexibility for working professionals and those balancing other commitments.

Another valuable pathway is marriage and family therapy. Accredited programs are now more accessible than ever, with online mft programs accredited for faster entry into the field. These programs can be a great fit for neuroscience graduates wanting to work directly with clients in counseling or therapy roles.

Those looking to start their career sooner may benefit from accelerated bachelors degrees that shorten the time to graduation without compromising educational quality. These fast-track options can be particularly helpful for adult learners returning to education or those seeking a career change.

Finally, if earning potential is a priority, it's smart to research the highest paying bachelor degrees in fields related to neuroscience and psychology. This ensures your educational investment aligns with your long-term career and financial goals.

Best Scientists Citing Siegfried Kasper

Trending Scientists

Recently Published Articles